These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 16846514)
21. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial. Sahai V; Catalano PJ; Zalupski MM; Lubner SJ; Menge MR; Nimeiri HS; Munshi HG; Benson AB; O'Dwyer PJ JAMA Oncol; 2018 Dec; 4(12):1707-1712. PubMed ID: 30178032 [TBL] [Abstract][Full Text] [Related]
22. Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. Knox JJ; Hedley D; Oza A; Siu LL; Pond GR; Moore MJ Ann Oncol; 2004 May; 15(5):770-4. PubMed ID: 15111345 [TBL] [Abstract][Full Text] [Related]
23. A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study. Iyer RV; Gibbs J; Kuvshinoff B; Fakih M; Kepner J; Soehnlein N; Lawrence D; Javle MM Ann Surg Oncol; 2007 Nov; 14(11):3202-9. PubMed ID: 17705089 [TBL] [Abstract][Full Text] [Related]
24. A case of extrahepatic bile duct cancer with distant metastases showing pathological complete response to treatment combining gemcitabine and cisplatin. Adachi K; Okuwaki K; Nishiyama R; Kida M; Imaizumi H; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Miyata E; Kumamoto Y; Koizumi W Clin J Gastroenterol; 2019 Oct; 12(5):466-472. PubMed ID: 30941639 [TBL] [Abstract][Full Text] [Related]
25. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Meyerhardt JA; Zhu AX; Stuart K; Ryan DP; Blaszkowsky L; Lehman N; Earle CC; Kulke MH; Bhargava P; Fuchs CS Dig Dis Sci; 2008 Feb; 53(2):564-70. PubMed ID: 17597402 [TBL] [Abstract][Full Text] [Related]
26. Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study. Asnacios A; Fartoux L; Romano O; Tesmoingt C; Louafi S S; Mansoubakht T; Artru P; Poynard T; Rosmorduc O; Hebbar M; Taieb J Cancer; 2008 Jun; 112(12):2733-9. PubMed ID: 18412149 [TBL] [Abstract][Full Text] [Related]
27. Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: report of four cases. Lee MA; Woo IS; Kang JH; Hong YS; Lee KS Jpn J Clin Oncol; 2004 Sep; 34(9):547-50. PubMed ID: 15466829 [TBL] [Abstract][Full Text] [Related]
28. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Alberts SR; Al-Khatib H; Mahoney MR; Burgart L; Cera PJ; Flynn PJ; Finch TR; Levitt R; Windschitl HE; Knost JA; Tschetter LK Cancer; 2005 Jan; 103(1):111-8. PubMed ID: 15558814 [TBL] [Abstract][Full Text] [Related]
29. Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study. Kullmann F; Hollerbach S; Dollinger MM; Harder J; Fuchs M; Messmann H; Trojan J; Gäbele E; Hinke A; Hollerbach C; Endlicher E Br J Cancer; 2009 Apr; 100(7):1032-6. PubMed ID: 19293797 [TBL] [Abstract][Full Text] [Related]
30. Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience. Kumar S; Masood N; Shaikh AJ; Valimuhammad AT; Haider G; Lal A; Niamatullah N Asian Pac J Cancer Prev; 2009; 10(3):463-6. PubMed ID: 19640192 [TBL] [Abstract][Full Text] [Related]
31. [A case of stage IVA intrahepatic biliary tract cancer successfully treated with gemcitabine]. Matsuo R; Kondo T; Ohshiro Y; Moon Y; Yamamoto Y; Takeshima T; Todoroki T; Ohkohchi N Gan To Kagaku Ryoho; 2006 Oct; 33(10):1501-4. PubMed ID: 17033247 [TBL] [Abstract][Full Text] [Related]
32. Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Kubicka S; Rudolph KL; Tietze MK; Lorenz M; Manns M Hepatogastroenterology; 2001; 48(39):783-9. PubMed ID: 11462924 [TBL] [Abstract][Full Text] [Related]